FPR2 agonist 3

Overview

FPR2 agonist 3 (compound CMC23) can limit the lactate dehydrogenase release in LPS ( HY-D1056 ) -stimulated cultures and decrease the levels of pro-inflammatory IL-1β and IL-6 . FPR2 agonist 3 decrease the level of phosphor-STAT3 via the STAT3/SOCS3 signaling pathway.

Application

Products | Products > Disease Areas > Depression | Products > Disease Areas > Pain | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Formyl Peptide Receptor (FPR)

Product Information

• Catalog No.: HY-155335
• CAS No.: 2829263-19-4
• Molecular Formula: C25H20F2N4O2
• Molecular Weight: 446.45
• Purity: 99.39%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source